These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 6150812)

  • 1. Congenital dysfibrinogenemia.
    Rupp C; Beck EA
    Curr Probl Clin Biochem; 1984; 14():65-130. PubMed ID: 6150812
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetically abnormal fibrinogens--strategies for structure elucidation, including fibrinopeptide analysis.
    Henschen A; Kehl M; Southan C
    Curr Probl Clin Biochem; 1984; 14():273-320. PubMed ID: 6391842
    [No Abstract]   [Full Text] [Related]  

  • 3. Structure and function of normal fibrinogen.
    Furlan M
    Curr Probl Clin Biochem; 1984; 14():38-64. PubMed ID: 6239754
    [No Abstract]   [Full Text] [Related]  

  • 4. Congenital dysfibrinogenemias. A review.
    Rocha E; Páramo JA; Aranda A; Cuesta B; Fernández J
    Ric Clin Lab; 1985; 15(3):205-29. PubMed ID: 3909359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fibrinogen Bern II: hereditary fibrinogen variant with amino acid substitution of arginine replaced by histidine in position 16 of the A alpha chain].
    Rupp C; Sievi R; Furlan M; Beck EA
    Schweiz Med Wochenschr; 1983 Oct; 113(40):1460-2. PubMed ID: 6648427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen Troyes--fibrinogen Metz. Two new cases of congenital dysfibrinogenemia.
    Soria J; Soria C; Samama M; Poirot E; Kling C
    Thromb Diath Haemorrh; 1972 Jul; 27(3):619-33. PubMed ID: 4662617
    [No Abstract]   [Full Text] [Related]  

  • 7. Two cases of dysfibrinogenemia characterized by abnormal FPB release: fibrinogen Madrid I & II.
    Borrell M; Vila L; Solá J; Coll I; Gómez N; González N; Rutllant ML
    Thromb Res; 1987 Mar; 45(5):591-9. PubMed ID: 3109061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen Barcelona I. Congenital dysfibrinogenemia characterized by defective release of fibrinopeptide A and fibrinogen degradation products.
    Vila V; Regañón E; Aznar J; Navarro G; Salas M
    Thromb Res; 1987 Mar; 45(5):437-49. PubMed ID: 2954261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of fibrinopeptide A and B beta 15-42 analysis in blood coagulo-fibrinolytic tests].
    Koshihara K; Fuzimaki M
    Nihon Rinsho; 1989 Dec; 48 Suppl():889-91. PubMed ID: 2622023
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrinogen Milano IV, another case of congenital dysfibrinogenemia with an abnormal fibrinopeptide A release (A alpha 16 Arg----His).
    Bögli C; Hofer A; Baudo F; Redaelli R; Furlan M
    Haemostasis; 1992; 22(1):7-11. PubMed ID: 1521828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysfibrinogenemia. A current perspective.
    Galanakis DK
    Clin Lab Med; 1984 Jun; 4(2):395-418. PubMed ID: 6388985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fibrinopeptide A (FPA), fibrinopeptide B (FPB) and fibrinopeptide Bbeta(15-42) (FPBbeta15-42)].
    Uchiba M; Okajima K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():615-7. PubMed ID: 15658404
    [No Abstract]   [Full Text] [Related]  

  • 13. Structure and function of fibrinogen.
    Doolittle RF
    Horiz Biochem Biophys; 1977; 3():164-91. PubMed ID: 328365
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on a family with dysfibrinogenemia.
    Mammen EF; Prasad AS; Au CC
    Thromb Diath Haemorrh; 1968 Jul; 19(3):03-4. PubMed ID: 5708123
    [No Abstract]   [Full Text] [Related]  

  • 15. The fibrinogenopathies.
    Morse EE
    Ann Clin Lab Sci; 1978; 8(3):234-8. PubMed ID: 350125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying thrombin-catalyzed release of fibrinopeptides from fibrinogen using high-performance liquid chromatography.
    Ng AS; Lewis SD; Shafer JA
    Methods Enzymol; 1993; 222():341-58. PubMed ID: 8412803
    [No Abstract]   [Full Text] [Related]  

  • 17. A kinetic method for characterization of heterogenous fibrinogen and its application to fibrinogen Grand Rapids, a congenital dysfibrinogenemia.
    Higgins DL; Lewis SD; Penner JA; Shafer JA
    Thromb Haemost; 1982 Oct; 48(2):182-6. PubMed ID: 6217579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital hypofibrinogenemia and recurrent placental abruption.
    Ness PM; Budzynski AZ; Olexa SA; Rodvien R
    Obstet Gynecol; 1983 Apr; 61(4):519-23. PubMed ID: 6828283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Factor XIII, its physiological significance (a review of the literature)].
    Baluda VP; Zhukova NA
    Probl Gematol Pereliv Krovi; 1973 Feb; 18(2):34-40. PubMed ID: 4271843
    [No Abstract]   [Full Text] [Related]  

  • 20. [Plasma fibrinopeptide A and fibrinopeptide B beta 15-42 levels in patients with Behçet's disease].
    Sunakawa M; Arai I; Okinami S
    Nippon Ganka Gakkai Zasshi; 1986 Jun; 90(6):871-4. PubMed ID: 3751789
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.